Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis.
Koch
Marcus
M
Mostert
Jop
J
De Keyser
Jacques
J
Tremlett
Helen
H
Filippini
Graziella
G
D002986:Clinical Trials as Topic / Q000592:standards* / Q000706:statistics & numerical data; D015897:Comorbidity; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D016899:Interferon-beta / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D017063:Outcome Assessment, Health Care; D010349:Patient Compliance / Q000706:statistics & numerical data; D012008:Recurrence; D015203:Reproducibility of Results; D015983:Selection Bias; D028761:Withholding Treatment / Q000706:statistics & numerical data
D007155:Immunologic Factors; D016899:Interferon-beta